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Abstract
Truncated proviruses of variable sizes are present in peripheral blood mononuclear cells (PBMC) of human immunodeficiency virus type
1 (HIV-1)-infected persons and simian immunodeficiency virus (SIV)-infected rhesus macaques. Here, we investigated whether the highly
deleted HIV and SIV proviruses are present in infected organisms as multiple copies or whether each truncated provirus is unique. Using
end-point dilution, multiple long-distance (LD) DNA PCR assays were run in parallel using DNA extracted from PBMC of seropositive,
treatment-naive persons and from lymph nodes of a rhesus monkey inoculated with cloned, full-length SIVmac239 DNA. The PCR products
were titrated and mapped. Most truncated proviruses were present in the DNA samples tested as single, nonintegrated molecules that differed
from one another in size and/or nucleotide sequence. These results indicate that truncated primate lentiviral sequences found in infected
tissues are unique or rare quasispecies that do not replicate significantly.
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Introduction
Extensively deleted human immunodeficiency virus type
1 (HIV-1) genomes of variable size are present in peripheral
blood mononuclear cells (PBMC) of HIV-1-infected per-
sons (Sanchez et al., 1997) and of rhesus macaques inocu-
lated with supercoiled plasmid DNA encoding full-length
simian immunodeficiency virus (SIV)mac239 (Pion et al.,
2001). In macaques inoculated with a single molecular
species of proviral SIV DNA, genomic diversity developed
within 4 weeks after inoculation, thus confirming the ge-
netic instability of retroviral genomes in vivo.
In this study, we investigated whether highly deleted
HIV-1 and SIV proviruses are present in infected organisms
as multiple copies or whether each truncated provirus is
present as a single copy. The presence of multiple copies of
a given truncated provirus would indicate that it replicates,
that the host cell harboring this provirus has divided repeat-
edly, or that the truncated provirus is formed from full-
length viral genomes by recombination that occurs multiple
times. Replication of defective HIV-1 and SIV proviruses in
integrated forms was demonstrated to coincide with the
replication of genomic DNA in dividing cultured cells
(Bernier and Tremblay, 1995; Folks et al., 1986; Kim et al.,
2001; Little et al., 1994; Trono et al., 1989). In addition, the
transcribed RNA of such truncated proviruses may be en-
capsidated and rescued by helper virus (Berkowitz et al.,
1995; Dropulic et al., 1996; Federico et al., 1995; Kaye et
al., 1995; Richardson et al., 1993). Resultant virus particles
could transduce truncated genomes to other cells. None of
these mechanisms has been demonstrated to occur in in-
fected organisms.
Another mechanism to generate multiple copies of a
given truncated provirus could be a specific “hot spot”
recombination process. Mapping of defective genomes in
HIV-1-infected individuals showed that the frequency of
deletions is proportional to their proximity to the central
part of viral genome, which is consistent with a deletion
mechanism involving a single polymerase jump during re-
verse transcription (Sanchez et al., 1997). This mechanism
showed no sequence specificity, as judged from the variable
patterns of highly deleted proviral bands detected in differ-
ent infected individuals (Sanchez et al., 1997).
The variability of extensively deleted proviruses was
also studied in PBMC of HIV-1-infected, antiviral drug-
naive individuals, who were long-term nonprogressors
(LTNP) from the French prospective asymptomatic long-
term (ALT) cohort (Candotti et al., 1999b), and in the lymph
nodes of rhesus macaques inoculated with full-length SIV-
mac239 DNA (Liska et al., 1999; Pion et al., 2001). Viral
load, which was the only significant variable parameter in
the ALT cohort, directly correlated with the quantity of
replication-competent virus in PBMC (Candotti et al.,
1999a, 1999b). In the same cohort, the viral load was in-
versely proportional to the levels of HIV-1-specific IgG2
antibodies and helper T cell type 1 (Th1) response (Ngo-
Giang-Huong et al., 2001). Because the formation of defec-
tive viruses is generally the consequence of frequent serial
passages at high multiplicities of infection (Barrett and
Dimmock, 1986; Huang and Marmur, 1970; Roux et al.,
1991; Sekellick and Marcus, 1980), we assumed that mul-
tiple copies of highly deleted proviruses could be found
more frequently in PBMC in individuals with high viral
loads than in individuals with low viral loads. For the same
reason, multiple copies of highly deleted fragments might
be more abundant in lymphoid tissue, where both HIV-1
and SIV preferentially replicate and where more replication-
competent helper virus is available compared to PBMC
(Embretson et al., 1993; Pantaleo et al., 1993; Pion et al.,
2001; Smit-McBride et al., 1998; Stahl-Henning et al.,
1999; Veazey et al., 1998).
Our experimental approach was based upon an assay to
detect identical copies of truncated proviruses in multiple
parallel long-distance (LD) DNA PCR runs followed by
Southern blot hybridization (Sanchez et al., 1997). We dem-
onstrated that truncated proviruses are not artificially gen-
erated during amplification reactions but are present in sam-
ple DNA before its amplification; thus, our LD-DNA PCR
technique was reliable. Because retrovirus replication criti-
cally depends on provirus integration into the host genome,
we tested integration of truncated proviruses by a modified
Alu sequence-based PCR strategy. Our results suggest that
most truncated lentiviral DNA fragments are not integrated
and represent unique or rare sequences.
Results
Truncated proviruses contain virus-specific sequences
First, we sought to establish that DNA bands smaller
than full-length provirus represent truncated proviral se-
quences rather than nonspecific PCR artifacts. To this end,
LD-DNA PCR products amplified from PBMC DNA of an
HIV-1-infected individual were cloned into plasmid
pNL4-3 (Sanchez et al., 1997), and the resulting pCESMO
plasmid was sequenced from the 5 noncoding sequence
(NCS) to the nef gene, across the deleted regions (Fig. 1).
Compared with the parental NL4-3 sequence, pCESMO
contained a simple deletion of 7695 nucleotides flanked at
either junction by direct repeats of the four nucleotides
AGCT. Short identical stretches flanking the deletion point
are characteristic of simple deletions within retroviral ge-
nomes (Omer et al., 1983; Pathak and Temin, 1990). The
remainder of the nucleotide sequences did not differ signif-
icantly from the HIV-1 NL4-3 genome. Similar results were
obtained from LD-DNA PCR products amplified from two
other HIV-positive individuals (not shown) (Sanchez et al.,
1997). Thus, we clearly established that short LD-DNA
PCR products represent specific viral sequences present in
infected cells.
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Extensively deleted HIV-1 sequences in PBMC DNA of
infected individuals are unique or rare quasispecies
Next, we tested whether extensively truncated fragments
of HIV proviruses are present in infected PBMC as multiple
copies or as unique quasispecies. Toward this end, six
aliquots of DNA extracted from PBMC of a single patient
were amplified in parallel at end-point dilution, using
primer pairs LTR(U5)/LTR(R) for three aliquots, or 5NCS/
nef for the other three, and were then analyzed by Southern
blot hybridization (Fig. 2). Among 15 bands obtained by
using primers LTR(U5)/LTR(R) (Figs. 2A and B, reactions
1, 2, 3), only two 5.7-kb bands (reactions 1 and 2) had the
same hybridization profile. Two additional 0.6-kb fragments
(Fig. 2B, reactions 2, 3, line 0.6 kb) were detected only with
the LTR(U3) probe, suggesting that they corresponded to
2-LTR circles. Repeated LD-DNA PCRs with primers
5NCS/nef resulted in the amplification of unique fragments
in most parallel runs (Figs. 2A and B, reactions 4, 5, 6).
Only two 1.4-kb bands (reactions 4 and 5) were the same.
Thus, the hybridization profiles of a total of 29 distinct
subgenomic DNA bands obtained in six parallel assays were
mostly different, suggesting that truncated HIV-1 DNAs in
PBMC are generally present as unique or rare copies. De-
spite differences in the fine molecular structure, five trun-
cated HIV-1 DNA fragments were obtained reproducibly in
reactions 1, 2, 3, 4, and 6, and six truncated fragments were
obtained reproducibly in reaction 5 (Fig. 2B).
Physical mapping of truncated HIV-1 proviral DNA was
repeated with similar results for three other HIV-1 seropos-
itive individuals: two AIDS patients and one LTNP (Fig. 3,
Table 1). Despite different LD-DNA PCR patterns in each
of several parallel amplifications, the number of truncated
proviral DNA bands was reproducible within each individ-
ual (Table 1).
As a control, we examined the pattern of HIV-1 se-
quences amplified from the PBMC DNA of a healthy donor
after cells had been infected in vitro with HIV-1 NL4-3. We
also amplified HIV sequences from genomic DNA of cul-
tured 8E5 cells chronically infected with HIV-1 LAV; these
cells do not produce infectious virus (Folks et al., 1986). A
9-kb band corresponding to full-length provirus was the
major LD-DNA PCR product (Fig. 2C). This result indi-
cates that under the reaction conditions used, the polymer-
ase system faithfully amplified its template, which consisted
predominantly of full-size HIV-1 DNA for these in vitro
infected cells. Given that full-length LD-DNA PCR prod-
ucts are more difficult to amplify than shorter proviral
fragments, these additional control experiments validate our
detection of multiply deleted proviral sequences in PBMC
DNA of infected individuals.
Lymph nodes of a macaque inoculated with SIV plasmid
DNA contain truncated proviruses that are unique or rare
Next, we sought to confirm our findings in a well-defined
primate model; we asked whether truncated proviruses
could be detected in lymph nodes of a macaque that had
become highly viremic after inoculation with cloned SIV-
mac239 plasmid DNA. We tested whether identical trun-
cated SIVmac239 DNA molecules could be detected repro-
ducibly by mapping of LD-DNA PCR products, or whether
truncated proviruses are present as unique species. At lim-
iting dilutions, six aliquots of DNA extracted from lymph
nodes of macaque 270W (Liska et al., 1999; Pion et al.,
2001) were amplified in parallel using primer pairs SIV-C/
SIV-nef and analyzed by Southern blot hybridization (Fig.
4).
We observed a similar pattern when comparing ethidium
bromide staining (Fig. 4A) with Southern blot hybridization
(Fig. 4B) of the same gel visualized by a random prime-
labeled probe containing the complete SIVmac239 DNA
sequence, indicating that most LD-DNA PCR products are
virus specific. Most bands visualized by a random prime-
labeled probe were detected also after rehybridization of the
same blot with oligonucletide probe SIV-LTR E (Fig. 4C
Fig. 1. DNA sequence of cloned truncated provirus pCESMO. The DNA
sequence determined from plasmids pCESMO using primers LTR(U5) and
LTR(R) was compared with the corresponding sequences of HIV-1 NL4-3.
Numbers in parentheses correspond to the length of sequence deleted from
HIV-1 NL4-3. The directly repeated sequences from HIV-1 NL4-3 and
truncated proviruses are underlined. Nested primers 5NCS and nef are
framed and cloning sites BssHII and XhoI are shown by arrows. For
localization of primers, see Fig. 2. The length of LD-DNA PCR product
amplified by primary primers LTR(U5) and LTR(R) corresponded to 1333
nt. The homology between the sequenced region and HIV-1 NL4-3 se-
quence upstream and downstream from the deletion junctions corre-
sponded to 95.4 and 87.2%, respectively.
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and E), indicating that LTR sequences are present in most
shortened proviruses. The intensity of the radioactive signal
obtained with the random prime-labeled probe is propor-
tional to the sizes as well as copy numbers of the amplified
fragments in each band. In contrast, the signal intensity
generated by oligonucleotide probe hybridization is propor-
tional only to the molarity of the amplified fragments re-
gardless of their sizes. This is shown by comparing hybrid-
ization with the complete SIVmac239 probe (Fig. 4B) to the
Fig. 2. Mapping of truncated forms of HIV-1 DNA. (A) Electrophoretic
mobility of HIV-1 DNA fragments of patient P1 amplified in triplicate by
primer pairs LTR(U5)/LTR(R) or 5NCS/nef visualized by Southern blot
hybridization with 32P-labeled LTR(U3) or nef oligonucleotide probe,
respectively. The numbers denote parallel LD-DNA PCRs. (B) Maps of
truncated viruses amplified in six parallel LD-DNA PCRs (nos. 1–6). The
organization of HIV-1 genome is shown in the top of the panel. Arrows
indicate the primers and their orientation. Numbers in parentheses corre-
spond to nucleotide positions in the HIV-1 LAI sequence. Hybridization
results for respective probes are shown for each reaction by , positive
signal, and, no signal. The size of truncated genomes was estimated from
their electrophoretic mobility. (C) HIV-1 DNA present in PBMC infected
in vitro with HIV-1 NL4-3 and from 8E5 cell line chronically infected with
HIV-1 LAV. The resulting product was probed by 32P-labeled nef oligo-
nucleotide. The total amount of DNA was adjusted to 1 g by DNA
extracted from PBMC cells from a healthy donor.
Fig. 3. Diversity of deleted HIV-1 DNAs in PBMC of infected individuals.
Repeated LD-DNA PCR of 0.2 g of DNA of patients P2 and P3 (A) and
LTNP no. 04.016 (B) visualized by Southern blot hybridization with
32P-labeled LTR(U3) oligonucleotide probes. Amplification product of the
genomic DNA of PBMC infected in vitro with HIV-1 NL4-3 was used as
a control.
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signal intensity obtained with probe SIV-LTR E (Fig. 4C),
which was inversely proportional to the fragment size. At
the selected exposition time of radioactive Southern blot,
the full-length SIVmac239 proviruses gave only weak sig-
nals with the oligonucleotide probe SIV-LTR E but hybrid-
ized strongly with the complete SIVmac239 probe (Fig.
4C). This result shows that the molar concentration of full-
length LD-DNA PCR products was lower than that of short
fragments and is consistent with our finding that the effi-
ciency of LD-DNA PCR is inversely proportional to the
logarithm of the fragment size (Sanchez et al., 1997). Full-
length SIV proviruses were readily detected by SIV-tat
probe (Fig. 4D). Preferential hybridization of the SIV-tat
probe to high-molecular-weight fragments indicates that, as
in PBMC of HIV-1-infected patients (Sanchez et al., 1997),
the highest frequency of deletions was detected in the center
of the SIV genome.
The hybridization profiles of all 24 distinct subgenomic
proviral DNA bands obtained in the six parallel assays and
listed in Fig. 4F all differed from one another (insufficient
resolution of small bands on the gel does not permit inter-
pretation of the patterns for bands migrating at or below 0.3
kb). We conclude that truncated SIV proviruses are gener-
ally present as unique or rare copies, thus confirming our
findings in HIV-1-infected individuals.
Coamplification with internal standard indicates that
truncated HIV-1 proviruses are present in genomic DNA
as single molecules
To confirm the uniqueness of truncated molecules, we
added an internal standard, pKSK, to each amplification
reaction of genomic PBMC DNA of two infected individ-
uals, nos. 04.008 and 06.006. We compared the number of
HIV-1 proviruses determined after LD-DNA PCR with the
number of pKSK standard molecules amplified in the same
reaction (Fig. 5). The initial number of proviruses present in
genomic PBMC DNA before amplification was extrapo-
lated from the standard curve generated with the number of
pKSK molecules before and after amplification.
The 5.8-kb pKSK standard encoded the target sequences
for LD-DNA PCR primers localized within HIV-1 LTR
(Fig. 5A, row c). The HIV-1 LTR sequences of the pKSK
standard enclosed the non-HIV, pUC18, part of pNL4-3,
that was specifically detected by the PUC43 probe (Fig. 5A,
row c and d). The number of pKSK copies after PCR was
estimated by comparing the intensity of hybridization signal
of a single 5.8-kb band with a known quantity of plasmid
pNL4-3 directly loaded to the agarose gel (Fig. 5B, lanes
g–i). The LD-DNA PCR amplification factor for the pKSK
internal standard was then calculated as the ratio of the
number of pKSK molecules after LD-DNA PCR reaction to
the known quantity of input pKSK molecules introduced
into the reaction. In a similar way as for the pKSK standard,
the number of HIV-1 proviruses after LD-DNA PCR was
estimated by comparing the intensity of the hybridization
signal, generated with the HIV-1-specific 5NCS probe,
with the known quantity of the pNL4-3 gel standard (Fig.
5C). Both probes PUC43 and 5NCS matched the pNL4-3
gel standard (Figs. 5B and C, lanes h and i), thus serving as
a hybridization standard compensating for the efficiency of
rehybridization with different probes. Reprobing of the
Southern blot with the 5NCS oligonucleotide probe re-
vealed DNA fragments of different sizes in each of the
parallel PCR reactions (Fig. 5C). The fact that the internal
standard amplified as a single band confirms that the vari-
able profile of PBMC DNA amplification is not a LD-DNA
PCR artifact, but that different truncated proviruses are
found in each of the amplified aliquots.
The estimated number of truncated proviruses present in
genomic PBMC DNA before amplification corresponded to
a single molecule (Fig. 5D). In these calculations, we did
not consider that the efficiency () of amplification by
LD-DNA PCR is dependent on the length of the target
sequence (  53  13  log bp; Sanchez et al., 1997).
When the LD-DNA PCR efficiency of the longest DNA
fragment (Fig. 5C, band 6, size  6 kb,   4.2) and of the
pKSK standard (size  5.8 kb,   4.1) was compared to
that of the shortest one (Fig. 5C, band 5, size  0.7 kb,  
16.3), the variability of  did not exceed a factor of 4 (Fig.
5D). This factor was neglected considering that the assessed
numbers of HIV-1 molecules before amplification varied
from 0.3 to 1.5, regardless of their molecular weight (Fig.
5D). However, these factors can reach highly significant
values (16-fold for band 5, size  0.7 kb) when truncated
forms are compared with full-length proviruses, amplified
with   1 (Sanchez et al., 1997). Indeed, 100 copies of the
full-length HIV-1 genome amplified about 108 times (Fig.
5C, lane g), reaching the same intensity as 1010 molecules of
the pNL4-3 gel standard (Fig. 5C, lane h), whereas the
truncated forms of HIV-1 proviruses amplified 109 times.
Taken together, both assays, one based on the mapping
of truncated molecules and the other on their coamplifica-
Table 1
Intraindividual variance of deleted HIV-1 DNAa
Individual Number of
truncated
proviral bands
per 200 ng of
DNA
Number of
repeated LD-
DNA PCR
Repeated/unique
bandsb
P1 4.3 	 0.6 3 2/15
P2 8.8 	 0.8 5 0/44
P3 3.2 	 1.3 5 0/16
No. 04.016 4.6 	 1.1 8 0/37
a Approximately 200 ng of human DNA, equivalent to 2  104 PBMC,
were amplified for each LD-DNA PCR. Parallel LD-DNA PCRs of four
infected individuals (for P1 see Fig. 2, for P2, P3, and LTNP no. 04.016,
see Fig. 3) were analyzed by Southern blot hybridization with LTR(U3)
probes, and the average number of bands per LD-DNA PCR was counted.
b Repeated bands were defined by the same electrophoretic mobility and
hybridization profile in Southern blot analysis as shown in detail in Fig. 2.
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tion with an internal standard, indicate that truncated HIV-1
DNA in PBMC of infected individuals are unique or rare
quasispecies. Similar results were obtained in AIDS patients
(Figs. 2 and 3) and LTNPs (Fig. 3).
Deletions in proviral DNA are most prevalent in the
center of the HIV-1 genome and are present before
LD-DNA PCR of PBMC DNA from infected individuals
In previous control experiments, we demonstrated that
the major LD-DNA PCR products in primary lymphocytes
infected in vitro consisted of full-length HIV-1 or SIV
sequences (Fig. 2C) (Pion et al., 2001; Sanchez et al., 1997).
This finding was in contrast to our results obtained by
amplification of PBMC DNA from infected persons or mon-
keys. However, it is still possible that HIV-1 DNA from
PBMC of infected individuals is more susceptible to recom-
bination by LD-DNA PCR than HIV-1 DNA from in vitro
cultivated cells. To verify the presence of deleted molecules
in PBMC, we tested whether one of the general conse-
quences of the deletion mechanism, a high frequency of
deletions in the center of HIV-1 genome (Sanchez et al.,
1997), was detectable before LD-DNA PCR. Standard
semiquantitative PCR with primer pairs tatA2/tatA1 and
nefII/LTR(R) (Fig. 2B) was used to compare the titers of
HIV-1 sequences from the central and terminal parts of the
HIV-1 genome, respectively (Fig. 6A). In PBMC DNA of
13 LTNPs with plasma viral RNA loads ranging from
800
to 480,000 copies per milliliter, the mean titer of the termi-
nal nef-LTR sequences was 5.5 	 5.0-fold higher (P 
0.0017) than that of the central tat sequences.
In a second assay, we tested whether cleavage of HIV-1
DNA in its central region would prevent amplification of
full-length and long subgenomic fragments yet have no
effect on the amplification of shorter products. Restriction
sites of endonucleases that rarely cleave the HIV-1 provirus
were mapped in genomic DNA from 10 individuals with the
aim of finding an enzyme that only cleaves the center of the
viral genome. The result of LD-DNA PCR performed be-
fore and after restriction cleavage of PBMC DNA of LTNP
no. 04.016 by EcoRI is shown in Fig. 6B. HIV-1 DNA of
Fig. 4. Physical mapping of extensively deleted forms of SIV DNA ex-
tracted from the lymph nodes of macaque 270W inoculated with super-
coiled plasmid DNA encoding the intact SIVmac239 genome. (A) Elec-
trophoretic mobility of SIV DNA fragments at limiting dilution amplified
in six parallel reactions by primer pairs SIV-C/SIV-nef visualized by
ethidium bromide. (B–D) Southern blot hybridization with either 32P-
random prime-labeled probe generated from the complete SIVmac239
genome (B), SIV-LTR E oligonucleotide probe (C), or SIV-tat oligonu-
cleotide probe (D). (E) The organization of the SIV genome. Arrows
indicate the primers and their orientation. Numbers in parentheses corre-
spond to nucleotide positions in the SIVmac239 sequence. (F) Physical
maps of truncated proviruses amplified in six parallel LD-DNA PCRs (nos.
1–6). Hybridization results for respective probes are shown for each
reaction by , positive signal, and , no signal. The size of truncated
genomes was estimated from their electrophoretic mobility.
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this individual was cut at positions 2.5 and 5.3 kb in the
standard HIV-1 map. The amplification of the full-length
and long subgenomic HIV-1 DNA fragments, detected by
hybridization with tat probe, was prevented by prior EcoRI
cleavage. Bands became detectable when the same mem-
brane was rehybridized with the LTR(U3) probe. Thus, both
assays suggest that deleted HIV-1 proviruses are present in
PBMC DNA before its amplification by LD-DNA PCR and
are not artifacts of this PCR strategy.
Truncated proviruses are not integrated in PBMC DNA of
HIV-1-infected individuals
To test whether truncated proviruses were integrated into
the host genome, we used a modified Alu sequence-based
PCR strategy (Fig. 7). In this modification, the junction
between the nearest Alu sequence and the HIV-1 provirus
was amplified by the primer pair Alu/nef. This was followed
by second-round PCRs with primers designed to amplify
either the LTR or the tat regions (Fig. 7A); the final PCR
products were visualized by hybridization for either the
terminal or the central proviral segments. We assumed that
due to the higher efficiency of PCR amplification of shorter
fragments, integrated forms of truncated proviruses would
be amplified preferentially compared to integrated forms of
full-length proviruses (Pion et al., 2001; Sanchez et al.,
1997, 1998). Therefore, if truncated proviruses were inte-
grated, the higher titers of HIV-1 sequences from the ter-
minal as compared to the central parts of the HIV-1 genome
(Fig. 6A) should be even more pronounced following Alu/
Fig. 5. Coamplification by LD-DNA PCR of HIV-1 DNA with the internal
standard. (A) Schematic representation of pNL4-3 (a, b) and an internal
standard pKSK (c, d) linearized by AatII and HindIII, respectively. LD-
DNA PCR products amplified by primers LTR(U5)/LTR(R) (b, d). Solid,
dotted, and dashed lines show HIV-1, human flank, and pUC18 sequences,
respectively (not in scale). Bold arrows represent complementary se-
quences for PUC43 or 5NCS oligonucleotide probes, specific for internal
standard and HIV-1 DNA, respectively. (B, C) Aliquots of 200 ng of DNA
extracted from PBMC of LTNPs nos. 04.008 and 06.006 were coamplified
with none (a, d), 1 (b, e), and 10 (c, f) copies of pKSK using LD-DNA PCR
primers LTR(U5) and LTR(R). The same membrane was hybridized with
32P-labeled PUC43 (B) and 5NCS (C) oligonucleotide probes. One hun-
dred input molecules of pNL4-3 were amplified in control LD-DNA PCR
without internal marker (g). A total amount of 1010 (h) and 109 (i) mole-
cules of pNL4-3 linearized by AatII was loaded onto the agarose gel
without previous PCR amplification (gel standard). It was used as external
hybridization standard to determine the number of pKSK (B) and HIV-1
DNA (C) molecules after LD-DNA PCR. Numbers in (C) show the bands
in which the amount of input molecules was determined. (D) Titration of
truncated HIV-1 proviruses in the PBMC of infected individuals. The
size-dependent amplification efficiency of LD-DNA PCR () was calcu-
lated according to the previously published formula   53  13  log bp
(Sanchez et al., 1997). The relative amplification efficiency of full-length
HIV-1 provirus according to this formula equals one. The amplification
factor is the ratio of pKSK molecules after and before LD-DNA PCR. The
number of proviral HIV-1 DNA molecules introduced into the LD-DNA
PCR was calculated as the ratio of the number of HIV-1 proviruses after
LD-DNA PCR to the pKSK amplification factor.
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nefPCR (Fig. 7A). In contrast, if truncated proviruses are
not integrated, Alu/nefPCR will only generate first-round
product from integrated, full-length proviruses, which will
yield equal titers of terminal and central sequences after the
second rounds of PCR and hybridization with probes for the
LTR or tat.
The titers of the terminal and central HIV-1 sequences
following Alu/nefPCR were determined for two LTNP, no.
04.016 (viral load, 4.8  105 copies/ml of plasma) and no.
09.006 (viral load, 4  104 copies/ml of plasma). Without
amplification by Alu/nefPCR, the titer ratios (Rt/c) of the
terminal to the central HIV-1 sequences were Rt/c  10 for
LTNP no. 04.016 and Rt/c  5 for LTNP no. 09.006.
Following Alu/nefPCR, the same titers of LTR and tat
sequences were found in the amplification products. This
shows that Alu/nefPCR preferentially amplified full-length
proviruses that contain tat and suggests that most truncated
HIV-1 proviruses are not integrated.
Discussion
Here we showed that truncated HIV-1 or SIV proviruses
detected in infected human or primate hosts are unique or
rare quasispecies that do not significantly replicate. The
uniqueness of the genomic structures of truncated provi-
ruses amplified in multiple parallel LD-DNA PCR runs was
demonstrated. Mapping showed that each truncated provi-
rus was present in PBMC and lymph node DNA only once,
as a single molecule. Titration of truncated HIV-1 provi-
ruses with an internal LD-DNA PCR standard confirmed
this conclusion.
Our studies showed that LD-DNA PCR faithfully ampli-
fied the template DNA and did not generate artificial re-
combinations. The frequency of recombination by Taq
polymerase during PCR is less than 5% (Meyerhans et al.,
1990) and is probably further reduced with the Pwo poly-
merase in the LD-DNA PCR system. Such a low recombi-
nation frequency cannot explain the presence of extensively
deleted molecules in PBMC and lymph nodes DNA. The
relative intensity of deleted bands was most frequently in-
versely proportional to their size, in a similar way as shown
previously for pairs of competing plasmids of different size
(Sanchez et al., 1997, 1998). However, many fragments did
not follow this general rule, especially when comparing
bands migrating closely together. Most likely, both compe-
tition among truncated fragments and variability of target
sequences for PCR primers and oligonucleotide probes were
responsible for the varying intensity of amplified bands.
We have studied the replication of HIV-1 in infected
individuals and of SIV in infected macaques by focusing on
the formation of truncated proviruses. Taken together, these
results provide further evidence that the majority of trun-
cated molecules are randomly formed during reverse tran-
scription of lentiviral genomes in infected cells. Thus, al-
though replication of defective proviruses was repeatedly
demonstrated in in vitro systems, it was not detected in our
experiments in which virus replication in vivo was assayed.
In the great majority, only single copies of truncated pro-
viruses were found in lymph nodes of SIVmac239-infected
macaques, although SIV replicates extensively in this tissue
(Smit-McBride et al., 1998; Stahl-Hennig et al., 1999; Vea-
Fig. 6. The highest frequency of deletions in the center of the HIV-1
genome is detected in PBMC before LD-DNA PCR. (A) Titers of HIV-1
sequences from the central and from the terminal parts of HIV-1 genome
per million cells were determined by standard semiquantitative PCR of
end-point dilution of DNA extracted from PBMC using primer pairs
tatA1/tatA2 and nefII/LTR(R). For localization, see Fig. 2B. An equiva-
lence of 1 g of human DNA to 105 PBMC was used to calculate cellular
virus load. (B) Sensitivity of LD-DNA PCR to cleavage by restriction
endonuclease EcoRI. PBMC DNA of LTNP no. 04.016 was cleaved (d–f,
j–l) or mock-treated (a–c, g–i) with 15 units of restriction endonuclease
EcoRI per microgram of DNA at 37°C for 4 h and amplified in triplicate
(200 ng of DNA per aliquot) by LD-DNA PCR using primer-pair
LTR(U5)/LTR(R). Southern blot was hybridized and rehybridized with
32P-labeled LTR(U3) and tat probes, respectively. EcoRI sites in the major
HIV-1 sequence of subject no. 04.016 were localized around positions 2.5
and 5.3 kb of standard HIV-1 map.
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zey et al., 1998). Thus, the higher quantity of full-length
virus present in lymph nodes in comparison with PBMC
(Pion et al., 2001) is not sufficient to provide a helper
function for replication of highly deleted forms. Similarly,
only single copies of truncated HIV-1 proviruses were de-
tected in the patients with a high viral load.
Integration of viral DNA into the host cell genome and
subsequent superinfection with a helper virus are both nec-
essary for the replication of truncated proviruses. By using
a modified Alu sequence-based PCR strategy, we have
shown that most truncated proviruses in PBMC of HIV-1-
infected individuals are not integrated. Free viral DNA is
present in PBMC in nonstable form and is rapidly degraded
with a half-life of about 1 day (Sharkey et al., 2000; Zack et
al., 1990). We have recently shown in a longitudinal fol-
low-up study of SIVmac239-infected macaques that trun-
cated proviruses do not continuously accumulate over the
period of infection in vivo (Pion et al., 2001). Instead of
continuous growth, the titers of deleted proviruses followed
titers of full-length SIVmac239 DNA, including their de-
cline after the peak of primary viremia. This provides fur-
ther evidence that truncated proviruses do not replicate and
indicates a limited life span and dynamic renewal of lym-
phocytes harboring truncated proviruses.
Our results suggest that truncated HIV genomes are only
rarely encapsidated—if at all—and therefore, do not signif-
icantly contribute to the formation of defective interfering
particles. Thus, possible interference seems to be limited to
interactions of truncated forms resident when infected cells
are superinfected with replication-competent helper virus.
Recent data have shown that HIV nef and tat, both of which
play important roles in lentiviral pathogenesis, can be ex-
pressed from unintegrated viral genomes (Wu and Marsh,
2001). Nef coding sequences were present in most truncated
proviruses. Besides down-modulation of CD4-receptor and
interference with superinfecting virus, nef expression might
protect cells harboring truncated proviruses against cytoxic
T lymphocyte killing by down-regulation of MHC I mole-
cules. Further quantitative studies in carefully selected
groups of HIV-1-infected patients presenting different virus
loads and different rates of progression towards AIDS will
be necessary to evaluate the biological significance and the
potential of truncated viruses for viral interference.
Materials and methods
Subjects
Seropositive individuals, who were anti-retroviral ther-
apy-naive, gave their informed consent. These individuals
were in the primary phase of HIV-1 infection or belonged to
the “ALT” cohort of LTNPs (Candotti et al., 1999a,b).
Criteria for inclusion in the ALT group were HIV-1 infec-
tion for no less than 8 years, an asymptomatic clinical
status, and a nondecreasing CD4 cell count 600/mm3
during the last 5 years. Plasma viral loads were determined
at the time of blood sampling.
Fig. 7. Unintegrated truncated proviruses in PBMC of LTNP individuals. (A) Schematic representation of modified Alu sequence-based PCR strategy to
detect integration of truncated proviruses into the host genome. PCR amplifications (Alu/nef) of existing Alu-HIV provirus junctions (dashed line) were
subjected to a second round of PCR with HIV-1-specific primers from the terminal (L2/L3) and the central (tatA2/tatA1) parts of the HIV-1 genome.
Full-length provirus is represented as integrated into the human genome (zigzag line). Truncated, nonintegrated provirus is shown by a dotted line. (B)
Amplification products of Alu/nefPCR of DNA extracted from PBMC of LTNP no. 04.016 and 09.006 contained the same amount of the terminal (LTR)
and central (tat) sequences. Genomic DNA isolated from PBMC of two LTNP was amplified by Alu/nefPCR followed by a second round of PCRs using either
the primer pairs L2/L3 or tatA2/tatA1. Amplification products were visualized by Southern blot hybridization with 32P-labeled oligonucleotide probes
LTR(U3) (for L2/L3) and tat (for tatA2/tatA1). 8E5 cells used as positive controls contain a single integrated HIV-1 genome.
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Animal care and DNA inoculation of monkey
The experiments with adult rhesus monkey 270W were
approved by the Animal Care and Use Committees at Bio-
qual, Inc. (Rockville, MD) and the Dana-Farber Cancer
Institute (Boston, MA). Ketamine anesthesia was used be-
fore all procedures that required the removal of the animal
from its cage. Macaque 270W was inoculated intramuscu-
larly with 500 g of supercoiled pBSIVmac239 as de-
scribed (Liska and Ruprecht, 1999).
DNA extraction
PBMC (106 cells) or lymph nodes biopsies (about 50
g) were frozen and kept at 70°C until DNA extraction.
High molecular weight genomic DNA was isolated as de-
scribed (Liska and Ruprecht, 1999; Sanchez et al., 1997).
PCR amplification of the -actin gene was used to test the
ability of the DNAs to be amplified and to ensure that
approximately equal amounts of genomic DNA were in-
cluded in the reactions.
PCR amplification of viral DNA
To amplify HIV-1 or SIV sequences, DNA samples in a
background of 100 ng of carrier human PBL DNA were
subjected to LD-DNA PCR in a 50 l reaction mixture
containing 50 mM Tris–HCI, pH 9.2, 14 mM (NH4)2SO4,
1.75 mM MgCI2, 350 M each dNTP and 45 pmol each of
LTR(U5) or 5NCS or SIV-C (sense) and LTR(R) or nef or
SIV-nef (antisense) primers (Figs. 2B and 4E), with 1.75
units of enzyme (Expand Long Template PCR system,
Roche, Basel, Switzerland) as described (Pion et al., 2001;
Sanchez et al., 1997). Viral origin (HIV-1 or SIV) is indi-
cated in the nomenclature of all SIV but no HIV-1 primers.
Reaction mixtures were then subjected to 40 amplification
cycles. The first 10 amplification cycles comprised a dena-
turing step of 10 s at 94°C, a primer-annealing step of 30 s
at 62°C, and a primer extension step of 8 min at 68°C. The
primer extension step of the following 15 amplification
cycles was gradually extended by 20 s at each cycle and
kept constant at 13 min for the last 15 cycles. A final
extension step of 7 min at 72°C was performed. In addition
to the whole internal sequence of HIV-1 provirus, LTR(U5)
and LTR(R) primers span the LTR-LTR junction of the
two-LTR circle and may generate a shorter amplification
product (595 nucleotides in the case of HIV-1 LAI).
The quantity of DNA molecules bearing either central or
terminal sequences of the HIV-1 genome was estimated by
semiquantitative PCR of tat and nef/LTR genes, respec-
tively. Tenfold dilutions of DNA were assayed in a standard
PCR reaction with Taq polymerase and tat A1 primer,
5-TGAGGAGGTCTTCGTCGCTGTCTCCGCT-3 (nt
5563–5590, antisense) and tat A2 primer, 5-TTGGGT-
GTCGACATAGCAGAATAGGCGT-3, (nt 5333–5360,
sense) for the presence of a 232-nt amplification product or
nefII primer, 5-GGAGCAGTATCTCGAGACCTG-
GAAA-3 (nt 8480–8504, sense) and the antisense LTR(R)
primer for the presence of 726 amplification product
(Sanchez et al., 1997; Sauvaigo et al., 1993; Fig. 2B). Serial
10-fold dilutions of plasmid pNL4-3 standard DNA were
amplified in the control experiment.
Southern blotting
PCR products were transferred to a Hybond N mem-
brane (Amersham, Life Science) and hybridized with 32P-
labeled oligonucleotide probes 5NCS, gag, pol, env, nef,
LTR(U3), tat 5-TTCCTGCCATAGGAGATGCCTAAG-
GCTT-3 (nt 5561–5588, antisense) and SIV-E as described
previously (Pion et al., 2001; Sanchez et al., 1997) (Figs. 2B
and 4E). In reprobing experiments, 32P-labeled oligonucle-
otides were stripped off from Hybond-N membrane in
0.1 SSC, 1% SDS at 70°C for 30 min. Hybridization was
repeated up to eight times without a detectable loss of
sensitivity. [32P]-dCTP-labeled probe containing complete
SIVmac239 sequences (1  109 dpm/g) was prepared
by Megaprime DNA Labelling System (Amersham Bio-
sciences, France) using as a template the viral part of the
plasmid pSIVmac239 amplified by LD-DNA PCR and
primer pairs SIV-C/SIV-nef.
Cloning of HIV-1 DNA fragments
LD-PCR products were separated by agarose gel elec-
trophoresis, electroeluted, and reamplified by LD-PCR us-
ing the nested primers 5NCS and nef to obtain sufficient
quantities of DNA for molecular cloning. The primers
5NCS and nef contain BssHII and XhoI restriction sites,
respectively, conserved in HIV-1 nucleic acid sequences
database. LD-PCR products were gel-purified, digested with
BssHII and XhoI to generate cohesive ends, and inserted by
homologous recombination into plasmid pNL4-3 (Sanchez
et al., 1997).
Construction of the internal standard for LD-DNA PCR
A pKSK plasmid of 5.8 kb was constructed by cleavage
of pNL4-3 by SacI, electropurification, and religation of the
vector, resulting in the elimination of the HIV-1 coding
sequence. pKSK contained a single HIV-1 LTR surrounded
by a non-HIV-1 DNA sequence. Taking into account that
shorter templates are amplified by LD-DNA PCR with a
higher efficiency than longer ones, the 5.8-kb sequence of
the internal standard revealed amplification kinetics similar
to those of plasmids bearing deleted (pCESMO, pFOCEP,
pNIPDJ) HIV-1 sequences (Sanchez et al., 1997, 1998).
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Titration of HIV-1 DNA deleted sequences by
coamplification with an internal standard
The DNA extracted from PBMC of infected persons was
coamplified by LD-DNA PCR with an internal standard
pKSK, previously linearized by digestion with HindIII in
the LTR. Linearization precluded a possible bias in the
amplification of the mixture of circular and linear forms
present in plasmid preparations. pKSK were specifically
detected by the 32P-labeled oligonucleotide PUC43 probe,
5-CGGTGCTACAGAGTTCTTGA-3, corresponding to
the pUC sequence (1257–1276, sense, Fig. 5A, rows c and
d), but lack sequences homologous to HIV-1-specific oli-
gonucleotide probes outside of LTR. The amplification
products were separated in an agarose gel together with a
known amount of non-PCR-amplified plasmid pNL4-3 con-
taining both HIV-1 and the pUC vector sequences (Fig. 5A,
row a). Southern blots were hybridized with the 32P-labeled
oligonucleotide 5NCS HIV-1-specific probe, stripped off,
and subsequently rehybridized with the PUC43 probe spe-
cifically detecting pUC sequence. The radioactivity in all
bands was determined by PhosphoImager (Fuji Inc., Japan).
Only limiting concentrations of internal standard (10 in-
put pKSK molecules per LD-DNA PCR reaction) were used
in this assay to prevent competitive inhibition of HIV-1
DNA amplification by the standard.
Restriction mapping and cleavage of patient HIV-1 DNA
Full-length HIV-1 DNA from PBMC of infected indi-
viduals was prepared by LD-DNA PCR using primer pair
LTR(U5)/LTR(R) followed by nested primers 5NCS/nef.
In the absence of sequence data for the HIV-1 genomes of
infected individuals, restriction mapping was performed by
single and double cleavage of HIV-1 DNA by the restriction
endonucleases BclI, EcoRI, NdeI, SalI, and StuI. After de-
termination of restriction sites, PBMC DNA of infected
individuals was cleaved with a restriction endonuclease
cutting the HIV-1 genome in its central part and not at its
extremities.
HIV-1 DNA-integration assay
The Alu-HIV-1 DNA junctions present in PBMC of
infected individuals were amplified by primers Alu (sense)
(Wu and Marsh, 2001) and nef (antisense) (Sanchez et al.,
1997); the amplification products were subjected to a sec-
ond round of PCR with HIV-1 LTR-specific primers L2/L3
(Wu and Marsh, 2001) and tat gene-specific primers tatA2/
tatA1. PCR products were visualized by hybridization with
32P-labeled oligonucleotide probes LTR(U3) or tat for
primer pairs L2/L3 or tatA2/tatA1, respectively. 8E5 cells
used as a positive control were obtained through the AIDS
Research and Reference Reagent Program from Dr. T. Folks
(Folks et al., 1986).
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